Atul A Deodhar (Atul Deodhar, A Deodhar)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 95

Top Topics

Ankylosing Spondylitis

Top Venues

Clinical rheumatology

Annals of the rheumatic diseases

ACR open rheumatology

Arthritis & rheumatology (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ashley Elliott, Tejpal Gill, Jaehwan Kim, Maria S Shutova, Oliver M FitzGerald, Stephen R Pennington, Madeleine Rooney, Atul A Deodhar, Siba P Raychaudhuri, Wolf-Henning Boehncke, Kurt de Vlam, Vinod Chandran, Wilson Liao
Advances in Psoriatic Disease Research: Insights From GRAPPA Pilot Research Awardees. The Journal of rheumatology (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Stefan Siebert, Laura C Coates, Larissa Valor-Méndez, Siba P Raychaudhuri, Warner Chen, Sheng Gao, Loqmane Seridi, Soumya D Chakravarty, May Shawi, Frederic Lavie, Mohamed Sharaf, Miriam Zimmermann, Alexa P Kollmeier, Xie L Xu, Proton Rahman, Phillip J Mease, Atul A Deodhar
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 76 (6) (2024)
Vibeke Strand, Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Miroslawa Nowak, Ayanbola Elegbe, Phillip J Mease, Atul A Deodhar
Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial. Arthritis care & research (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology (2024)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, Diamant Thaҫi, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph Frank Merola, Iain B McInnes, Atul A Deodhar
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical rheumatology (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Matthew A Brown, Martin Rudwaleit, Floris A van Gaalen, Nigil Haroon, Lianne S Gensler, Carmen Fleurinck, Alexander Marten, Ute Massow, Natasha de Peyrecave, Thomas Vaux, Katy White, Atul A Deodhar, Irene van der Horst-Bruinsma
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Annals of the rheumatic diseases (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Stefan Siebert, Laura C Coates, Larissa Valor-Méndez, Siba P Raychaudhuri, Warner Chen, Sheng Gao, Loqmane Seridi, Soumya D Chakravarty, May Shawi, Frederic Lavie, Mohamed Sharaf, Miriam Zimmermann, Alexa P Kollmeier, Xie L Xu, Proton Rahman, Phillip J Mease, Atul A Deodhar
Modulation of IL-23 Signaling With Guselkumab in Biologic-Naïve Patients Versus TNF Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Atul A Deodhar, Jerzy Supronik, Alan Kivitz, Guillermo Valenzuela, Karen Kapur, Susanne Rohrer, Eva Dokoupilova, Hanno B Richards, Karel Pavelka
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From the Randomized, Placebo-Controlled, Phase III INVIGORATE-1 Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Atul A Deodhar, Xenofon Baraliakos, Marina Magrey, Lianne S Gensler, Amit V Thorat, Surya Kiran Pemmaraju, Mary Jane Cadatal, Peter Nash
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials. The Journal of rheumatology 51 (8) (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of Secukinumab Versus Adalimumab Biosimilar on Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: Results From a Head-to-Head Randomized Phase IIIb Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (8) (2024)
Mohamad Bittar, Atul A Deodhar
A critical view of WHO guidelines on management of low back pain. Nature reviews. Rheumatology 20 (4) (2024)
Lars Erik Kristensen, Atul A Deodhar, Ying Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D Kinch, Dafna D Gladman
Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data. Rheumatology and therapy 11 (3) (2024)
Atul A Deodhar, Xenofon Baraliakos, Marina Magrey, Lianne S Gensler, Amit V Thorat, Surya Kiran Pemmaraju, Mary Jane Cadatal, Peter Nash
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials. The Journal of rheumatology (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology (2024)
Atul A Deodhar, Xenofon Baraliakos, Marina Magrey, Lianne S Gensler, Amit V Thorat, Surya Kiran Pemmaraju, Mary Jane Cadatal, Peter Nash
Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis by Baseline C-Reactive Protein Level: Post Hoc Analysis of Phase II and Phase III Clinical Trials. The Journal of rheumatology 51 (8) (2024)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, Diamant Thaҫi, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph Frank Merola, Iain B McInnes, Atul A Deodhar
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical rheumatology 43 (8) (2024)
Filip E Van den Bosch, Atul A Deodhar, Denis Poddubnyy, Walter P Maksymowych, Désirée Mfm van der Heijde, Tae Hwan Kim, Kishimoto Mitsumasa, Xenofon Baraliakos, Yihan Li, Kristin M D'Silva, Peter Wung, In-Ho Song
Upadacitinib in Active Non-radiographic Axial Spondyloarthritis: 1-Year Data From a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial. ACR open rheumatology 6 (8) (2024)
Daniela Kampel Stolnicki, Laura C Coates, Charlotte E Gollins, Sahil Koppikar, Lourdes Maria Perez-Chada, Lluis L Puig, Philip S Helliwell, Atul A Deodhar, Christopher T Ritchlin, Samuel T Hwang, Cláudia Goldenstein-Schainberg
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease. The Journal of rheumatology (2024)
Stefan Siebert, Laura C Coates, Larissa Valor-Méndez, Siba P Raychaudhuri, Warner Chen, Sheng Gao, Loqmane Seridi, Soumya D Chakravarty, May Shawi, Frederic Lavie, Mohamed Sharaf, Miriam Zimmermann, Alexa P Kollmeier, Xie L Xu, Proton Rahman, Phillip J Mease, Atul A Deodhar
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 76 (6) (2024)
Vibeke Strand, Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Miroslawa Nowak, Ayanbola Elegbe, Phillip J Mease, Atul A Deodhar
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial. Arthritis care & research 76 (8) (2024)
Mohamad Bittar, Atul A Deodhar
A critical view of WHO guidelines on management of low back pain. Nature reviews. Rheumatology (2024)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, Diamant Thaҫi, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph Frank Merola, Iain B McInnes, Atul A Deodhar
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical rheumatology 43 (8) (2024)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, Diamant Thaҫi, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph Frank Merola, Iain B McInnes, Atul A Deodhar
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical rheumatology 43 (8) (2024)
Matthew A Brown, Martin Rudwaleit, Floris A van Gaalen, Nigil Haroon, Lianne S Gensler, Carmen Fleurinck, Alexander Marten, Ute Massow, Natasha de Peyrecave, Thomas Vaux, Katy White, Atul A Deodhar, Irene van der Horst-Bruinsma
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials. Annals of the rheumatic diseases (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Atul A Deodhar, Alan J Kivitz, Marina Magrey, Jessica A Walsh, Philip J Mease, Maria Greenwald, Farid Kianifard, Chelsea Elam, Gopi M Bommidi, Adam Winseck, Lianne S Gensler
A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment. Rheumatology (Oxford, England) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Christopher T Ritchlin, Phillip J Mease, Wolf-Henning Boehncke, Diamant Thaҫi, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph Frank Merola, Iain B McInnes, Atul A Deodhar
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study. Clinical rheumatology 43 (8) (2024)
Vibeke Strand, Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Miroslawa Nowak, Ayanbola Elegbe, Phillip J Mease, Atul A Deodhar
Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial. Arthritis care & research (2024)
Stefan Siebert, Laura C Coates, Larissa Valor-Méndez, Siba P Raychaudhuri, Warner Chen, Sheng Gao, Loqmane Seridi, Soumya D Chakravarty, May Shawi, Frederic Lavie, Mohamed Sharaf, Miriam Zimmermann, Alexa P Kollmeier, Xie L Xu, Proton Rahman, Phillip J Mease, Atul A Deodhar
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Xenofon Baraliakos, Mikkel Østergaard, Denis Poddubnyy, Désirée van der Heijde, Atul A Deodhar, Pedro M Machado, Victoria Navarro-Compán, Kay-Geert A Hermann, Kishimoto Mitsumasa, Eun Young Lee, Lianne S Gensler, Uta Kiltz, Marco F Eigenmann, Patricia Pertel, Aimee Readie, Hanno B Richards, Brian Porter, Juergen Braun
Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: Results from a head-to-head randomized phase IIIb study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Proton Rahman, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, Phillip J Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, Dennis G McGonagle
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis. Clinical rheumatology 43 (5) (2024)
Sonam Kiwalkar, Richard A Howard, Dongseok Choi, Atul A Deodhar
A mixed methods study to uncover impediments to accurate diagnosis of nonradiographic axial spondyloarthritis in the USA. Clinical rheumatology (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Xenofon Baraliakos, Atul A Deodhar, Désirée Mfm van der Heijde, Marina Magrey, Walter P Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S Gensler
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies. Annals of the rheumatic diseases (2023)
Holly L Rosenzweig, Emily E Vance, Kofi Asare-Konadu, Kylie V Koney, Ellen J Lee, Atul A Deodhar, Rouhin Sen, Liron Caplan, Ruth J Napier
Card9/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Annals of the rheumatic diseases (2023)
Atul A Deodhar, Denis Poddubnyy, Proton Rahman, Joerg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung, Désirée Mfm van der Heijde
Long-term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program. The Journal of rheumatology (2023)
Dennis McGonagle, Iain B McInnes, Atul A Deodhar, Larissa Valor-Méndez, May Shawi, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Stephen Xu, Christopher T Ritchlin, Proton Rahman, Phillip J Mease
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies. ACR open rheumatology (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Victoria Navarro-Compán, Xenofon Baraliakos, Marina N Magrey, Andrew Östör, Christopher D Saffore, Manish Mittal, In-Ho Song, Fabiana Ganz, Jayne Stigler, Atul A Deodhar
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis. Rheumatology and therapy (2023)
Atul A Deodhar, Natalie J Shiff, Cinty Gong, Eric K H Chan, Elizabeth C Hsia, Kim Hung Lo, Alianu Akawung, Lilianne Kim, Stephen Xu, John D Reveille
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study. Rheumatology and therapy (2023)
Désirée Mfm van der Heijde, Atul A Deodhar, Xenofon Baraliakos, Matthew A Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S Gensler, Nigil Haroon, Marina Magrey, Walter P Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip E Van den Bosch, Thomas Vaux, Huji Xu
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials. Annals of the rheumatic diseases (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Christopher T Ritchlin, Atul A Deodhar, Wolf-Henning Boehncke, Enrique Roberto Soriano, Alexa P Kollmeier, Xie L Xu, Federico Zazzetti, May Shawi, Yusang Jiang, Shihong Sheng, Philip S Helliwell
Multidomain Efficacy and Safety of Guselkumab Through 1 Year in Patients With Active Psoriatic Arthritis With and Without Prior Tumor Necrosis Factor Inhibitor Experience: Analysis of the Phase 3, Randomized, Placebo-Controlled DISCOVER-1 Study. ACR open rheumatology 5 (3) (2023)
Atul A Deodhar, Helena Marzo-Ortega, Joseph Wu, Cunshan Wang, Oluwaseyi Dina, Keith S Kanik, Lara Fallon, Lianne S Gensler
Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease-Modifying Antirheumatic Drug Use: A Post Hoc Analysis. ACR open rheumatology (2023)
Laura C Coates, Atul A Deodhar
Is Axial Psoriatic Arthritis the Same as Ankylosing Spondylitis With Psoriasis: A Debate. The Journal of rheumatology (2023)
Beverly Cheok Kuan Ng, Deepak R Jadon, Adewale O Adebajo, Gizem Ayan, Kristina Callis Duffin, Vinod Chandran, Laura C Coates, Maria Antonietta D'Agostino, Kurt de Vlam, Atul A Deodhar, Lihi Eder, Amit Garg, Dafna D Gladman, Niti Goel, Alice B Gottlieb, M Elaine Husni, Arnon M Katz, Arthur Kavanaugh, Ennio Lubrano, Phillip J Mease, Joseph Frank Merola, Peter Nash, Philip S Helliwell, Stephen R Pennington, Lourdes Maria Perez-Chada, Fabian Proft, Cheryl F Rosen, Laura Savage, Cláudia Goldenstein-Schainberg, Stefan Siebert, Enrique Roberto Soriano, Ingrid Steinkoenig, William Tillett, April W Armstrong, Oliver M FitzGerald
Proceedings of the GRAPPA 2022 Executive Retreat. The Journal of rheumatology (2023)
Atul A Deodhar, Tejpal Gill, Marina N Magrey
Human Leukocyte Antigen B27-Negative Axial Spondyloarthritis: What Do We Know? ACR open rheumatology (2023)
Marina N Magrey, James Cheng-Chung Wei, Arne Yndestad, Andrew G Bushmakin, Joseph C Cappelleri, Oluwaseyi Dina, Atul A Deodhar
Relationships of Work Productivity and Activity Impairment with Patient-Reported Outcomes in Ankylosing Spondylitis: Results from Two Trials. Arthritis care & research (2023)
Dafna D Gladman, Phillip J Mease, Paul Bird, Enrique Roberto Soriano, Soumya D Chakravarty, May Shawi, Frederic Lavie, Cinty Gong, Evan Leibowitz, Denis Poddubnyy, Lai Shan Tam, Philip S Helliwell, Arthur Kavanaugh, Atul A Deodhar, Mikkel Østergaard, Xenofon Baraliakos
Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?' by Braun and Landewé. Annals of the rheumatic diseases (2022)
Désirée Mfm van der Heijde, Lianne S Gensler, Walter P Maksymowych, Robert B M Landewe, Martin Rudwaleit, Lars Bauer, Thomas Kumke, Mindy Kim, Simone Emanuele Auteri, Bengt Hoepken, Atul A Deodhar
Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study. RMD open 8 (1) (2022)
Laura C Coates, Philip Mease, Andris Kronbergs, Cameron Helt, David Sandoval, So Young Park, Bernard Combe, Peter Nash, Atul A Deodhar
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Clinical rheumatology 41 (10) (2022)
M Elaine Husni, Atul A Deodhar, Sergio Schwartzman, Soumya D Chakravarty, Elizabeth C Hsia, Jocelyn H Leu, Yiying Zhou, Kim H Lo, Arthur Kavanaugh
Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis research & therapy 24 (1) (2022)
Xenofon Baraliakos, Atul A Deodhar, Maxime Dougados, Lianne S Gensler, Anna Molto, Josef S Smolen, Alan J Kivitz, Denis Poddubnyy, Marga Oortgiesen, Thomas Vaux, Carmen Fleurinck, Julie Shepherd-Smith, Christine de la Loge, Natasha de Peyrecave, Désirée van der Heijde
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study. Arthritis & rheumatology (Hoboken, N.J.) (2022)
Phillip J Mease, Atul A Deodhar
Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review. BMC musculoskeletal disorders 23 (1) (2022)
Philip C Robinson, Pedro M Machado, Nigil Haroon, Lianne S Gensler, John D Reveille, Vanessa Taieb, Thomas Vaux, Carmen Fleurinck, Marga Oortgiesen, Natasha de Peyrecave, Atul A Deodhar
Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study. ACR open rheumatology 4 (9) (2022)
Phillip J Mease, Atul A Deodhar, Désirée Mfm van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Annals of the rheumatic diseases 81 (6) (2022)
Désirée Mfm van der Heijde, Xenofon Baraliakos, Joachim Sieper, Atul A Deodhar, Robert D Inman, Hideto Kameda, Xiaofeng Zeng, Yunxia Sui, Xianwei Bu, Aileen L Pangan, Peter Wung, In-Ho Song
Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial. Annals of the rheumatic diseases 81 (11) (2022)
Philip C Robinson, Walter P Maksymowych, Lianne S Gensler, Stephen Hall, Martin Rudwaleit, Bengt Hoepken, Lars Bauer, Thomas Kumke, Mindy Kim, Natasha de Peyrecave, Atul A Deodhar
Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study. ACR open rheumatology 4 (9) (2022)
Atul A Deodhar, Suleman Bhana, Kevin Winthrop, Lianne S Gensler
COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis. Rheumatology and therapy 9 (4) (2022)
Atul A Deodhar, Bernard Combe, Ana P Accioly, Rebecca Bolce, Danting Zhu, Amanda M Gellett, Aubrey Trevelin Sprabery, Gerd-Rüdiger R Burmester
Safety of ixekizumab in patients with psoriatic arthritis: data from four clinical trials with over 2000 patient-years of exposure. Annals of the rheumatic diseases 81 (7) (2022)
Abhijeet Danve, Atul A Deodhar
Treatment of axial spondyloarthritis: an update. Nature reviews. Rheumatology 18 (4) (2022)
Francisco Airton Castro Rocha, Atul A Deodhar
Rebuttal letter on "Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature". Clinical rheumatology 40 (5) (2021)
Atul A Deodhar, Désirée van der Heijde, Joachim Sieper, Filip Van den Bosch, Walter P Maksymowych, Tae Hwan Kim, Kishimoto Mitsumasa, Andrew Ostor, Bernard Combe, Yunxia Sui, Alvina D Chu, In-Ho Song
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension. Arthritis & rheumatology (Hoboken, N.J.) (2021)
Atul A Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée Mfm van der Heijde
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study. Annals of the rheumatic diseases (2021)
Jeffrey R Curtis, Kevin Winthrop, Rhonda L Bohn, Robert Suruki, Sarah Siegel, Jeffrey L Stark, Fenglong Xie, Huifeng Yun, Lang Chen, Atul A Deodhar
The Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan Databases. ACR open rheumatology 3 (11) (2021)
Jeffrey R Curtis, Stacey S Cofield, S Louis Bridges, John R Bassler, Atul A Deodhar, Theresa L Ford, Joseph Huffstutter, Allen Jankeel, Alan J Kivitz, Shaila Kamal, Stephen Lindsey, Ilhem Messaoudi, Norma Mendoza, Kaleb D Michaud, Ted R Mikuls, David Ridley, William Shergy, Sarah A R Siegel, Kevin L Winthrop
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial. Annals of internal medicine 174 (11) (2021)
Atul A Deodhar, S D Chakravarty, C Cameron, S Peterson, R Hensman, S Fogarty, P Spin, S Kafka, S Nair, L S Gensler
A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis. Clinical rheumatology 39 (8) (2020)
Atul A Deodhar, Corine Miceli-Richard, Xenofon Baraliakos, Helena Marzo-Ortega, Dafna D Gladman, Ricardo Blanco, Ayan Das Gupta, Ruvie Martin, Jorge Safi, Brian Porter, Abhijit Shete, James Todd Rosenbaum
Incidence of Uveitis in Secukinumab-treated Patients With Ankylosing Spondylitis: Pooled Data Analysis From Three Phase 3 Studies. ACR open rheumatology 2 (5) (2020)
Francisco Airton Castro Rocha, Ana Carolina Matias Dinelly Pinto, Jailson Rodrigues Lopes, Atul A Deodhar
Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis-time to reconsider treatment guidelines? A case series and review of literature. Clinical rheumatology 40 (5) (2020)
Tore K Kvien, Philip Gerard Conaghan, Laure Gossec, Vibeke Strand, Mikkel Østergaard, Denis Poddubnyy, Nicole Williams, Brian Porter, Abhijit Shete, Isabelle Gilloteau, Atul A Deodhar
Secukinumab Provides Sustained Reduction in Fatigue in Patients with Ankylosing Spondylitis: Long-term Results of Two Phase III Randomized Controlled Trials. Arthritis care & research (2020)
Atul A Deodhar, Philip Mease, Proton Rahman, Victoria Navarro-Compán, Helena Marzo-Ortega, Theresa Hunter, David Sandoval, Andris Kronbergs, Luis Leon, Mingyang Shan, Ann Leung, Kurt De Vlam, Vibeke Strand
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial. Rheumatology and therapy 8 (1) (2020)
Atul A Deodhar, Ricardo Blanco, Eva Dokoupilová, Stephen Hall, Hideto Kameda, Alan J Kivitz, Denis Poddubnyy, Marleen van de Sande, Anna S Wiksten, Brian O Porter, Hanno B Richards, Sibylle Haemmerle, Jürgen Braun
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (1) (2020)
Abhijeet Danve, Atul A Deodhar
Rebuttal letter to Dr. Fallahi's letter about our manuscript "Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities." Clin Rheumatol. 2018 Dec 26. https://doi.org/10.1007/s10067-018-4397-3. Clinical rheumatology 38 (5) (2019)
Stefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, Kristian Reich, Atul A Deodhar, Iain B McInnes, Brian Porter, Ayan Das Gupta, Luminita Pricop, Todd Fox
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Annals of the rheumatic diseases 78 (4) (2019)
Abhijeet Danve, Atul A Deodhar
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clinical rheumatology 38 (3) (2018)
Daniel M Hartung, Kirbee Johnston, David M Cohen, Thuan Nguyen, Atul A Deodhar, Dennis N Bourdette
Elephant in the room. Annals of the rheumatic diseases 78 (2) (2018)
Désirée Mfm van der Heijde, Atul A Deodhar, James C Wei, Edit Drescher, Dona Fleishaker, Thijs Hendrikx, David Li, Sujatha Menon, Keith S Kanik
Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Annals of the rheumatic diseases 76 (8) (2017)
Jürgen Braun, Xenofon Baraliakos, Atul A Deodhar, Dominique Baeten, Joachim Sieper, Paul Emery, Aimee Readie, Ruvie Martin, Shephard Mpofu, Hanno B Richards, null null
Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study. Annals of the rheumatic diseases 76 (6) (2016)
Charles Peterfy, Vibeke Strand, Lu Tian, Mikkel Østergaard, Ying Lu, Julie DiCarlo, Peter Countryman, Atul A Deodhar, Robert Landewé, Veena K Ranganath, Orrin Troum, Philip G Conaghan
Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials. Annals of the rheumatic diseases 76 (6) (2016)
Atul A Deodhar, Vibeke Strand, Jonathan Kay, Juergen Braun
The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Annals of the rheumatic diseases 75 (5) (2016)
Joachim Sieper, Atul A Deodhar, Helena Marzo-Ortega, Jacob A Aelion, Ricardo Blanco, Tseng Jui-Cheng, Mats Andersson, Brian Porter, Hanno B Richards, null null
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study. Annals of the rheumatic diseases 76 (3) (2016)